BENMELSTOBART

Clinical trials for BENMELSTOBART explained in plain language.

Never miss a new study

Get alerted when new BENMELSTOBART trials appear

Sign up with your email to follow new studies for BENMELSTOBART, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Triple threat: new hope for liver cancer patients who failed first treatment?

Disease control Not yet recruiting

This study tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few spots and stopped responding to initial therapy. The goal is to see if this triple therapy can control the cancer longe…

Matched conditions: BENMELSTOBART

Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control

Last updated May 11, 2026 20:39 UTC

BENMELSTOBART

Get alerted when new BENMELSTOBART trials appear

Triple threat: new hope for liver cancer patients who failed first treatment?